Application of extracorporeal membrane oxygenation combined with intra-aortic balloon pump for adult patients with fulminant myocarditis and cardiogenic shock

台适,孙佳星,唐建军,张志辉,潘宏伟,陈雅琴,贺嘉,朱清一,周胜华

DOI: https://doi.org/10.3760/cma.j.cn101460-20200423-00045

2020-01-01

Abstract:Objective:To investigate the clinical implications of extracorporeal membrane oxygenation (ECMO) in adult patients with fulminant myocarditis (FM) and cardiogenic shock (CS).Methods:Patients who received ECMO due to FM complicated by CS between March 2017 and September 2019 from 3 hospitals in Hunan Province were enrolled. The clinical data, outcomes and complications after ECMO implantation were collected and compared to those before ECMO implantation. Patients were divided into ECMO alone and ECMO combined with intra-aortic balloon pump (IABP) (combination group), and baseline data and outcomes were compared between these two subgroups.Results:A total of 15 patients were enrolled with a median (interquartile range) age of 29 (27, 50) years and 9 were female. Six patients suffered cardiac arrest and 6 patients underwent continuous renal replacement therapy (CRRT). After ECMO implantation, there was a significant decrese in NT-proBNP levels (median value: 8 759.0 pg/mL vs. 2 964.0 pg/mL, P=0.002), decrease in blood lactate levels (median value: 5.1 mmol/L vs. 1.7 mmol/L, P=0.008), increaase in pH (7.3±0.2 vs. 7.4±0.1, P=0.026) and increase in left ventricualr ejection fraction detected by echocardiography [(34.3±10.9)% vs. (50.0±11.7)%, P=0.004]. Of the 15 patients, 8 patients implanted ECMO alone, other 7 patients needed ECMO combined with IABP therapy. Compared with ECMO alone group, patients in combination group were more likely to have cardiac arrest and need CRRT (both P<0.05). As to the complications after ECHO implantation, 6 patients suffered from acute renal failure and received CRRT, 4 patients suffered from vascular complications. As a whole, 11 patients (11/15) successfully weaned from ECMO and survived to discharge, of which, 7 patients (7/8) in the ECMO alone group and 4 patients (4/7) in combination group weaned from ECMO and survived to discharge. Conclusions:ECMO was effective in hemodynamic support for patients with FM and CS, and ECMO combined with IABP therapy usually was used in patients wth cardiac arrest. Starting combination therapy as early as possible may be crucial for outcomes of patients with FM and CS.